Atlas Brown,Inc. Edwards Lifesciences Corp Transaction History

Atlas Brown,Inc.

$288 Million
Q4 2024

A detailed history of Atlas Brown,Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Atlas Brown,Inc. holds 6,464 shares of EW stock, worth $454,742. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,464

Previous 6,449 0.23%

Holding current value

$454,742

Previous $425,000 12.47%

% of portfolio

0.17%

Previous 0.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 10, 2025	BUY	$64.54 - $75.92 $968 - $1,138	15 Added 0.23%	6,464 $478,000
Q3 2024 Oct 18, 2024	BUY	$59.7 - $93.78 $30,805 - $48,390	516 Added 8.7%	6,449 $425,000
Q2 2024 Jul 23, 2024	BUY	$84.3 - $94.31 $1,264 - $1,414	15 Added 0.25%	5,933 $548,000
Q1 2024 Apr 08, 2024	BUY	$72.54 - $95.56 $362 - $477	5 Added 0.08%	5,918 $565,000
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $5,098 - $6,417	50 Added 0.85%	5,913 $696,000
Q4 2021 Jan 18, 2022	SELL	$106.37 - $130.68 $53,185 - $65,340	-500 Reduced 7.86%	5,863 $760,000
Q2 2020 Jul 21, 2020	BUY	$57.54 - $76.95 $251,047 - $335,732	4,363 Added 218.15%	6,363 $440,000
Q2 2019 Jul 24, 2019	SELL	$55.74 - $64.41 $18,617 - $21,512	-334 Reduced 14.31%	2,000 $369,000
Q2 2018 Jul 11, 2018	SELL	$42.45 - $51.3 $7,810 - $9,439	-184 Reduced 7.31%	2,334 $343,000
Q1 2018 Apr 17, 2018	SELL	$37.19 - $47.45 $7,958 - $10,154	-214 Reduced 7.83%	2,518 $351,000
Q4 2017 Jan 25, 2018	SELL	$33.79 - $39.39 $1,081 - $1,260	-32 Reduced 1.16%	2,732 $341,000
Q3 2017 Oct 12, 2017	BUY	$36.29 - $38.83 $100,305 - $107,326	2,764	2,764 $302,000

Others Institutions Holding EW

# of Institutions

1,364

Shares Held

470M

Call Options Held

9.76M

Put Options Held

3.89M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Brown,Inc. with notifications on news.

Account